Outcomes of chemoradiotherapy in cervical cancer - The Western Australian experience

International Journal of Radiation Oncology Biology Physics

Volumn 82, Issue 4, 2012, Pages 1431-1438

  Lim, Adeline ^a   Sia, Serena ^a  

^a ROYAL PERTH HOSPITAL   (Australia)

Author keywords

Brachytherapy; Cervix carcinoma; Chemoradiation; Outcomes

Indexed keywords

ASSESSING OUTCOMES; BRACHYTHERAPY; CERVICAL CANCERS; CERVIX CARCINOMA; CHEMORADIATION; CIS-PLATIN; COX REGRESSION ANALYSIS; DISEASE FREE SURVIVAL; HAZARD RATIO; HIGH-DOSE RATE BRACHYTHERAPY; KAPLAN-MEIER METHOD; LOCAL CONTROL; LOCOREGIONAL RECURRENCE; MULTI VARIATE ANALYSIS; OUTCOMES; OVERALL SURVIVAL; PRE-TREATMENT; PROGNOSTIC FACTORS; TREATMENT TIME; WESTERN AUSTRALIA;

CHEMORADIOTHERAPY; HEMOGLOBIN; ONCOLOGY; PATIENT MONITORING; PLATINUM COMPOUNDS; REGRESSION ANALYSIS;

RADIOTHERAPY;

CISPLATIN; HEMOGLOBIN;

ADULT; AGED; ARTICLE; AUSTRALIA; BLADDER IRRIGATION; BRACHYTHERAPY; CANCER MORTALITY; CANCER RECURRENCE; CANCER STAGING; CHEMORADIOTHERAPY; DISEASE FREE SURVIVAL; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; HEMORRHAGIC CYSTITIS; HUMAN; MAJOR CLINICAL STUDY; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RADIATION DOSE; RECTOVAGINAL FISTULA; SIDE EFFECT; TREATMENT OUTCOME; TUMOR VOLUME; URINARY FREQUENCY; URINE INCONTINENCE; UTERINE CERVIX CANCER;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; BRACHYTHERAPY; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; CISPLATIN; DISEASE-FREE SURVIVAL; FEMALE; HEMOGLOBIN A; HUMANS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; RETROSPECTIVE STUDIES; UTERINE CERVICAL NEOPLASMS; WESTERN AUSTRALIA;

EID: 84857924231     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2011.04.047     Document Type: Article

References (26)

1. A. Jemal, F. Bray, and M. Center Global cancer statistics CA Cancer J Clin 61 2011 69 90
2. Australian Institute of Health and Welfare and Australasian Association of Cancer Registries Cancer in Australia: an overview, 2008 Cancer series no. 46; Cat. no. CAN 42 2008 Australian Institute of Health and Welfare Canberra
3. C.C. Carmo, R.R. Luiz, and G. Silva The effect of addition of chemotherapy in the treatment of women with cervical cancer: A survival analysis using propensity score Gynecol Oncol 111 2008 271 275
4. M. Morris, P.J. Eifel, and J. Lu Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer N Engl J Med 340 1999 1137 1143
5. P.G. Rose, B.N. Bundy, and E.B. Watkins Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer N Engl J Med 340 1999 1144 1153
6. C.W. Whitney, W. Sause, and B.N. Bundy Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in Stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: A Gynecology Oncology Group and Southwest Oncology study J Clin Oncol 17 1999 1339 1348
7. J.A. Green, J.J. Kirwan, and J. Tierney Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix Cochrane Databse Syst Rev 3 2005 CD002225.pub2 DOI: 10.1002/14651858.CD002225.pub2
8. H. Lukka, H. Hirte, and A. Fyles Concurrent cisplatin-based chemotherapy plus radiotherapy for cervical cancer - a meta-analysis Clin Oncol 14 2002 203 212
9. S. Nag, B. Erickson, and B. Thomadsen The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the cervix Int J Radiat Oncol Biol Phys 48 2000 201 211
10. K. Parker, E. Gallop-Evans, and L. Hanna Five years' experience treating locally advanced cervical cancer with concurrent chemoradiotherapy and high-dose-rate brachytherapy: Results from a single institution Int J Radiat Oncol Biol Phys 74 2009 140 146
11. I.L. Atahan, C. Onal, and E. Ozyar Long-term outcome and prognostic factors in patients with cervical carcinoma: A retrospective study Int J Gynecol Cancer 17 2007 833 842
12. L. Souhami, R. Seymour, and T.N. Roman Weekly cisplatin plus external beam radiotherapy and high dose rate brachytherapy in patients with locally advanced carcinoma of the cervix Int J Radiat Oncol Biol Phys 27 1993 871 878
13. T. Toita, H. Moromizato, and K. Ogarwa Concurrent chemoradiotherapy using high dose rate intracavitary brachytherapy for uterine cervical cancer Gynecol Oncol 96 2005 665 670
14. R. Lanciano, A. Calkins, and B.N. Bundy Randomized comparison of weekly cisplatin or protracted venous infusion of fluorouracil in combination with pelvic radiation in advanced cervix cancer: A Gynecologic Oncology Group Study J Clin Oncol 23 2005 8289 8295
15. R. Potter, J. Dimopoulos, and P. Georg Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer Radiother Oncol 83 2007 148 155
16. R. Grigiene, K.P. Valuckas, and E. Aleknavicius The value of prognostic factors for uterine cervical cancer patients treated with irradiation alone BMC Cancer 7 2007 234
17. A. Duenas-Gonzalez, J.J. Zarba, and J.C. Alcedo A Phase III study comparing concurrent gemcitabine (Gem) plus cisplatin (Cis) and radiation followed by adjuvant Gem plus Cis versus concurrent Cis and radiation in patients with Stage IIB to IVA carcinoma of the cervix J Clin Oncol 27 Suppl 2009 18s
18. K. Serkies, A. Badzio, and J. Jassem Clinical relevance of hemoglobin level in cervical cancer patients administered definitive radiotherapy Acta Oncol 45 2006 695 701
19. S. Mercadante, V. Gebbia, and A. Marazzo Anemia in cancer: Pathophysiology and treatment Cancer Treat Rev 26 2000 303 311
20. M. Grogan, G.M. Thomas, and I. Melamed The importance of hemoglobin levels during radiotherapy for carcinoma of the cervix Cancer 86 1999 1528 1536
21. A.W. Fyles, M. Milosevic, and M. Pintile Anemia, hypoxia and transfusion in patients with cervical cancer: A review Radiother Oncol 57 2000 13 19
22. C.A. Perez, P.W. Grigsby, and H. Castro-Vita Carcinoma of the uterine cervix: Impact of prolongation of overall treatment time and timing of brachytherapy on outcome of radiation therapy Int J Radiat Oncol Biol Phys 32 1995 1275 1288
23. S.W. Chen, J.A. Liang, and Y.C. Hung Concurrent weekly cisplatin plus external beam radiotherapy and high-dose rate brachytherapy for advanced cervical cancer: A control cohort comparison with radiation alone on treatment outcome and complications Int J Radiat Oncol Biol Phys 66 2006 1370 1377
24. T. Nakanishi, H. Ishikawa, and Y. Suzuki A comparison of prognoses of pathological Stage IB adenocarcinoma and squamous cell carcinoma of the uterine cervix Gynecol Oncol 79 2000 289 293
25. M.P. Hopkins, and G.W. Morley A comparison of adenocarcinoma and squamous cell carcinoma of the cervix Obstet Gynecol 77 1991 912 917
26. J.H. Farley, K.W. Hickey, and J.W. Carlson Adenosquamous histology predicts a poor outcome for patients with advanced-stage, but not early-stage, cervical carcinoma Cancer 97 2003 2196 2202